We studied the cell wall of a Candida albicans laboratory mutant exhibiting a high minimum inhibitory concentration (MIC; 8 μ g ml Ϫ1 ) for caspofungin without bearing FKS1 mutations. This strain showed a reduced level of ß 1,3 D glucan (0.43 ϫ ) and a higher chitin content (2.3 ϫ ) than a control strain even when grown without caspofungin. No signifi cant over-or under-expression of chitin synthase or chitinase genes was observed. However, point mutations were detected in the chitinase 2 and 3 genes. These mutations, which may affect the enzymatic activity of the encoded protein products involved in the degradation of the chitin, could have led to an increased concentration of that component, allowing the strain to compensate for its low ß 1,3 D glucan content and the effect of caspofungin.
Introduction
Recently, the Infectious Diseases Society of America (IDSA) guidelines indicated an increased importance of echinocandins for the treatment of Candida infections [1] . However, the widespread use of these antifungal drugs could lead to the emergence of resistant strains, reducing the clinical effi ciency of this new class of molecules. For this reason, it is of particular interest to understand the molecular mechanisms leading to such resistances.
Several studies have already been performed on these mechanisms [2 -4] in Candida albicans . In the present work, we investigated these mechanisms in a laboratory mutant of Candida albicans exhibiting diminished susceptibility to cas pofungin. The strain, called CaInR (for Candida albicans induced resistance) was obtained by continuous in vitro selection pressure with caspofungin. The MIC of CaInR for caspofungin is 8 μ g ml Ϫ1 and this strain did not bear the mutations in the FKS1 gene. The latter are usually described et al . and is susceptible to caspofungin (CAS; MIC CaInS ϭ 0.25 μ g ml Ϫ1 ). The CaInR [14] strain with an elevated minimum inhibitory concentration (MIC) for caspofungin was obtained by continuous antifungal selection pressure on CaInS. Briefl y, CaInS was grown in RPMI 1640 (Gibco) culture medium with CAS (0.25 μ g ml Ϫ1 ) at 37 ° C under shaking. The RPMI-CAS culture medium was replaced every 48 h. After 7 days, the yeast exhibited a MIC of 0.5 μ g ml Ϫ1 . This isolate was then maintained in RMPI-CAS medium (CAS ϭ 0.5 μ g ml Ϫ1 ) for a 7-day cycle and the process described above was repeated. The concentration of CAS was increased progressively over a period of 4 months until an isolate (CaInR) with a high MIC to CAS (8 μ g ml Ϫ1 ) was obtained. CaInR did not showed any paradoxical effects at high drug concentrations, as has been described for C. albicans strains under CAS exposure [15, 16] , and was considered a non-CAS susceptible isolate as defined by Pfaller et al . [17] . The entire FKS1 gene of CaInR was sequenced and showed no mutations, even in hotspot I or hotspot II, which is un-expected for a strain that is not susceptible to caspofungin [2 -4] . Finally, this isolate was subcultured 16 times (over 8 weeks) on Sabouraud plates without caspofungin, and the MIC tested by the Clinical and Laboratory Standards Institute (CLSI) M27 A3 method was found to be stable.
Cell wall component assay
CaInS and CaInR were grown in RPMI under constant shaking ( ϫ 200 g ) at 37 ° C with or without 0.25 μ g ml Ϫ1 of CAS. After 24 h of growth, the yeast was retrieved by centrifugation, washed three times in PBS and frozen in liquid nitrogen. One hundred milligrams of each sample was used for further cell wall component assays. The cell pellets were fi rst heat shocked in a water bath (100 ° C for fi ve min) and cooled on ice for 10 min. The cells that were intended to be assayed for mannan and chitin content were incubated in 1 ml of PBS (pH 5.0) containing Aspergillus niger β glucanase (1.2 U ml Ϫ 1 , Biochemika) at 37 ° C for 1 h, washed three time in PBS pH 7.0 and then lysed as described below. This step was not used with cells assayed for β 1,3 D glucan content, which were directly lysed in 1 ml of PBS (pH 7.0) using 0.22 -0.25-mm sterile silica beads (B. Braun Biotech ® , Germany) in a Magnalyser apparatus (Roche) under shaking (four cycles of 60 sec each at 6500 rpm). The cell lysate solution was then retrieved and sonicated for 30 min in a Branson 2010 apparatus. Cell lysis was controlled by microscopy and the mechanical lysis and sonication steps were repeated if needed until at least 90% of the yeast cells were lysed. The cell lysate solution was centrifuged for 5 min at 2400 g to remove any remaining whole cells and then centrifuged for 30 min at 13,600 g . The pellet obtained was then analyzed as follows:
(1) For the β 1,3 D glucan content assay the pellet obtained was incubated with an anti-β 1-3 D glucan (1/100) monoclonal antibody (Biosupplies, Australia) in PBS solution. Incubation was performed for 1 h at 37 ° C and then after three additional washings, the pellet was incubated with a second FITC-labelled antibody (1/200) for 1 h at 37 ° C. (2) For the mannan content assay the lysis pellet was retrieved and incubated fi rst with an anti-mannan (1/100) monoclonal antibody for 1 h at 37 ° C (Biosupplies, Australia). After washing, the lysis pellet was incubated with a second FITC-labeled antibody (1/200) for 1 h at 37 ° C. (3) For the chitin content assay the lysis pellet was retrieved and directly incubated with an anti-chitin probe consisting of a Bacillus circulans chitinase A1 chitin-binding domain fused to the C-terminus of the maltose binding protein of E. coli and labeled by FITC (1/200) (Sigma). Incubation was performed for 1 h at 37 ° C.
After washing, the samples were fed in triplicate directly into 96-well plates in a Victor III apparatus at 540 nm and compared with a corresponding standard composed of commercial S. cerevisiae β 1,3 D glucan, S. cerevisiae mannan or crab shell chitin powder in solution (Sigma). Experiments were performed three separate times for each cell wall component.
Sugar reducing assay
One hundred milligrams of nitrogen frozen wild-type CaInS and mutant CaInR cells grown with or without CAS were lysed as described in the section above. After the lysis step, the resulting solution was centrifuged for 5 min at 2400 g to remove non-lysed cells and then again for 30 min at 13,600 g . The pellet obtained was washed three times with PBS and diluted in 100 μ l of distillated water. The total sugar content of the cell lysis extract was determined using the phenol-sulfuric acid method of Dubois et al . [18] in comparison with a glucose-mannose mix (60:40) standard calibration.
Quantifi cation of gene expression
CaInS and CaInR cells grown in RPMI with or without CAS (0.25 μ g ml Ϫ1 ) as described above were used for quantification of gene expression. The same CAS concentration was chosen for both strains (although it did not cor respond to the MIC of CaInR) to avoid possible expression-level deviations due to major differences in the concentration of CAS if grown at their respective MIC (MIC CaInS ϭ 0.25 μ g ml Ϫ1 and MIC CaInR ϭ 8 μ g ml Ϫ1 ).
Macherey Nagel) following the manufacturer ' s instructions. The purity and the quantity of DNA were assessed by spectrophotometry (Biophotometer, Eppendorf). The DNA templates were used for the PCR amplifi cation of CHT1, CHT2, CHT3 and CHT4 genes for both strains with the Platinum PCR Supermix (Invitrogen). The respective primer pairs are described in Table 1 . The conditions used were those recommended by the manufacturer. The PCR products were then separated by migration on 1% agarose TAE gels, stained with ethidium bromide and visualized under UV light. The amplicons were cloned into a PCR-II vector and inserted into competent E. coli (PCR II TOPO TA Cloning Kit, Invitrogen). Five positive (white clones) were selected for each gene and each strain. Plasmids were extracted using the NucleoSpin Plasmid Quickpure Kit (Macherey-Nagel) and checked by enzymatic E coRI digestion. Two clones for each strain and each gene were sequenced (Cogenics, France).
Hyphal growth assay
To determine whether hyphal growth was identical between the CaInS reference strain and the corresponding mutant CaInR, yeast of each strain were inoculated in 0.5 ml of human serum and incubated under shaking at 180 rpm for 4 h at 37 ° C. Observations were made with an Olympus BX41 microscope.
Chitinase enzymatic assay
One hundred milligrams of fresh wild-type CaInS or CaInR mutant cells were lysed in 500 μ l PBS using 0.22 -0.25-mm sterile silica beads (B.Braun Biotech, Germany) in a Magnalyser apparatus (Roche) under shaking (four cycles of 30 sec each at 6500 rpm) with cooling on ice between each cycle. The lysates were centrifuged at 13,600 g for 15 min at 4 ° C. For each sample, 500 μ l of lysate supernatant was incubated with 500 μ l of PBS solution containing 10 mg/ml of Chitin Azure (Sigma) at pH 7.0. The lysate pellets for each sample were retrieved in 500 μ l of PBS and incubated in the The same amount (100 mg) of frozen CaInS and CaInR cells were used for total RNA extraction with the Ribopure ™ -Yeast Kit (Ambion) following the manufacturer ' s instructions. Retrieved tRNA was measured and adjusted to perform cDNA synthesis with the same amount of tRNA for each sample. cDNA was synthesized using the Superscript VILO cDNA synthesis kit (Invitrogen) as recommended by the manufacturer. Synthesized cDNA was measured and adjusted if needed, and qPCR was performed using the LightCycler Fast Start DNA Master I Kit within a LightCycler 1.5 apparatus (Roche). This was conducted for the four genes encoding chitin synthases ( CHS1, CHS2, CHS3 and CHS8 ) and the four genes encoding the chitinases ( CHT1, CHT2, CHT3 and CHT4 ) in C. albicans and for each sample (CaInS, CaInS ϩ CAS, CaInR, CaInR ϩ CAS). The primers used are presented in Table 1 . The PCR parameters were as follows; denaturation for 10 s at 95 ° C followed by 40 cycles of amplifi cation (5 s at 95 ° C, 5 s at 50 ° C and 30 s at 72 ° C) and melting curve (95 ° C for 0 s, 51 ° C for 30 s, 95 ° C for 0 s with a slope of 0.1 ° C/s and a step size of 0.2 ° C). The quantity of material was measured by absolute quantifi cation in comparison with the standard curve obtained by amplifi cation of a known range of PCR products specifi c for each gene. The results were read with automatic correction with the LightCycler ® Software 4.05 (Roche). All experiments were performed at least four times for each gene.
Chitinase gene sequences
DNA was extracted from frozen pellets of CaInR and CaInS yeast cells by incubating them for 30 min at 75 ° C in 200 μ l Cell Lysis Buffer Solution (Promega), to which 25 μ l of Proteinase K solution (Promega) was added. After incubation, 200 μ l of BQ1 buffer was added (QuickPure NucleoSpin Blood Kit, Macherey Nagel), and the entire extract was lysed with 0.22 -0.25-mm silica beads by shaking in a Magnalyser apparatus (four cycles of 20 s at 6000 rpm). Two hundred microliters of 100% ethanol was added and the supernatant was retrieved and processed though silica columns (QuickPure NucleoSpin Blood Kit, Table 1 Primers.
Gene
Forward primer Reverse primer
same solution of Chitin Azure as above. Incubation was performed for 24 h at 37 ° C under constant shaking (200 rpm) in an Incubator 1000 (Heidolph). After incubation, all samples were centrifuged for 10 min at 13,600 g . The OD of each assay supernatant was read at 595 nm using a Libra S4 (Biochrom) apparatus. Since one C. albicans chitinase (Cht3p) is secreted [19, 20] , the chitinase activity for both strains was tested in culture supernatants by harvesting 100 mg of fresh CaInS or CaInS cells, washing them twice in PBS and then incubating at 37 ° C under shaking for 3 h in 1 ml of liquid Sabouraud medium. After 3 h, the cells were pelleted by centrifugation (12,000 g for 10 min) and the supernatants were retrieved. These supernatants were incubated with 1 ml of PBS (pH 7.0) containing 10 mg ml Ϫ1 of Chitin Azure as described above. After 24 h of incubation, the culture supernatant/PBS/Chitin Azure reaction mix was centrifuged for 10 min at 13,600 g and the OD was read as described above. The baseline OD was the OD read for each sample under the same conditions at T ϭ 0. The assays were performed in the same way on three independent cultures for CaInS and CaInR issued samples. One enzyme unit was defi ned as a change in optical density ( Δ OD 595 ) of 0.1 per 24 h.
Results

Quantifi cation of cell wall components
CaInR is a laboratory mutant with a high caspofungin MIC without any mutations in the FKS1 gene that have been previously described [14] . This strain was found to have a lower level of ß 1,3 D glucans than the reference strain (CaInS) when grown in RPMI without CAS (46.9 μ g mg Ϫ1 of cells in CaInR versus 106.9 μ g mg Ϫ1 of cells in CaInS; Table 2 ). Therefore, the amount of ß 1,3 D glucans in CaInR was equivalent to 0.43 ϫ that detected in CaInS without any CAS interference. In the presence of CAS, the level of ß 1,3 D glucans decreased (reaching 31.9 μ g mg Ϫ1 of cells in CaInR and 89.3 μ g mg Ϫ1 of cells in CaInS) showing a ratio of 0.35 ϫ between the two strains (Table 1) .
Both strains displayed the same concentrations of mannan in their cell walls whether exposed to CAS or not (Table 1) .
Finally, concerning chitin content, CaInR had a higher amount (2.3 ϫ ) of chitin in the absence of CAS induction (19.8 μ g mg Ϫ1 of cells) than CaInS grown under the same conditions (8.5 μ g mg Ϫ 1 of cells; Table 1 ). In the presence of CAS, CaInS exhibited a slight but signifi cant increase in chitin content, reaching 11.3 μ g mg Ϫ1 of cells. Under the same conditions, CaInR reached 20.5 μ g of chitin per mg of cells, showing no signifi cant difference in its chitin content when grown with or without CAS ( Table 2 ). The chitin content ratio between CaInR and CaInS in the presence of the antifungal drug was 1.8 ϫ .
Quantifi cation of gene expression
To explain the difference in chitin content, the level of expression of the four chitin synthase and four chitinase genes was determined by qRT-PCR in the two strains in the presence and absence of CAS (Table 3) . Among the eight genes, six showed statistically signifi cant differences ( P Ͻ 0.05) in their expression levels when compared strain to strain or between the strains with or without drug induction. These were the CHS1, CHS2 and CHS8 chitin synthase genes and the CHT1, CHT2 and CHT4 chitinases genes (Table 3 ). However, among these genes, fi ve showed gene-to-gene expression level ratios within a range of 0.25 -4 ϫ . This range corresponds to a Cp difference of Ϯ 1.2 cycles and was considered to be biologically irrelevant according to the manufacturer (Roche). Only one gene ( CHS2 ) showed both statistically and biologically significant variations in its expression level (Table 3) . Indeed, the CHS2 chitin synthase gene showed an up-regulation in the presence of CAS both in CaInS and CaInR when compared to the same strains grown in the absence of the antifungal drug. CHS2 was 38.6 ϫ more expressed in CaInS in the presence of CAS than in the same strain in absence of CAS ( Table 3 ). CHS2 was also 381.3 ϫ more expressed in CaInR in the presence of CAS than in the same strain in the absence of the drug. A comparison between CaInS and CaInR revealed no difference in the level of expression of the gene in the absence of the drug, but there was a difference of up-regulation between the strains in the presence of CAS. CHS2 expression was higher in CaInR than in CaInS in the presence of the same concentration of CAS (0.25 μ g ml Ϫ1 ) giving a ratio of 8.3 ϫ .
Chitinases single mutations
Four chitinases, CHT1, CHT2, CHT3 and CHT4 genes of CaInR were amplifi ed by PCR with a high-fi delity enzyme and then cloned and sequenced. A gene-to-gene sequence comparison was performed between CaInR and CaInS. There were not mutations of CHT1 and CHT4 in CaInR, whereas three and two single mutations were noted with CHT2 and CHT3 respectively. These mutations led to the predicted amino acid substitutions P460S, Q462K and A479S in Cht2p and K97N and N233D substitutions in Cht3p (Fig. 1) . For Cht2p, the predicted amino acid substitutions were localized outside the active site of the enzyme, while for Cht3p, the amino acid substitutions were localized both in the active enzymatic site and in the substrate binding cleft of the protein.
Hyphal growth
The ability of CaInR to form hyphae in human serum was assessed microscopically and compared with the observations found with the CaInS strain. At t ϭ 0, hyphae were not observed ( Fig. 2 IA and IIA ), but after 4 h of incubation, the CaInS strain was able to form normal hyphae as would be expected for a wild-type Candida albicans strain under such conditions (Fig. 2 IB and IC) . In contrast, the CaInR laboratory mutant appeared to form very few hyphae and those formed were mostly abnormal ( Fig. 2 IIB and IIC) .
Chitinase enzymatic assay
Given the presence of mutations in both the CHT2 and CHT3 genes of CaInR which may have altered the enzymatic activities of the encoded protein products, a chitinase enzymatic activity assay was performed to compare results obtained with CaInR to those of CaInS which lacked these mutations. This assay showed that a cell lysis supernatant of 100 mg of CaInS wild-type yeast exhibited a Δ OD 595 of 0.074 (corresponding to 0.74 U of enzyme; Fig. 3 ) after 24 h of incubation with Chitin Azure. In contrast, cell lysis supernatant of CaInR for the same quantity of cells and for the same incubation time, showed a Δ OD 595 of 0.025 (corresponding to 0.25 U of enzyme; Fig. 3) . None of the strains exhibited signifi cant chitinase activity in the cell lysis pellet fractions. These results show that the laboratory mutant CaInR exhibits less than 40% (0.34 ϫ ) of the chitinase activity detected in the corresponding CaInS reference strain in the cell lysis supernatant. The assays of the culture supernatants showed the same results as a ΔOD595 of 0.044 (corresponding to a chitinase activity of 0.44 U of enzyme (Fig. 3) ) was detected for the wild-type CaInS strain while a ΔOD595 of 0.016 (0.16 U of enzyme (Fig. 3) ) was detected for the CaInR mutant within these . Expression levels and standard deviations are indicated as 10 Ϫ4 ng of specifi c cDNA per μ g of total cDNA. Expression level ratios: expression levels were compared for each strain (CaInS and CaInR) and each sample: (i) within the same strains between yeasts grown in the absence or presence of CAS, and (ii) between strains when both strains were grown in the absence or presence of CAS.
Gene expression level (10 Ϫ4 ng/ μ g of cDNA) Gene expression level ratios
samples under the same experimental conditions. Therefore, the chitinase activity within the culture supernatant (corresponding to the secreted Cht3p activity) of our CaInR mutant was 0.36 ϫ the activity of the wild-type strain.
Discussion
Resistance mechanisms to echinocandin are of increasing interest, especially given the expected increase in the use of these drugs for the management of candidiasis [1] .
The main mechanism of resistance described for Candida albicans is the occurrence of point mutations in two ' hotspots ' areas of the FKS1 gene, which encodes the Fks1p sub-unit of the ß glucan synthase. However, aside from these hotspots, other mechanisms leading to resistance to this antifungal drug must be considered. Although rare, high echinocandins MICs in the absence of FKS1 mutations have already been described in Candida isolates [21] . Moreover, the biosynthesis and the plasticity of the cell wall are dynamic phenomena under the control of genes other than those implicated in the β 1,3 glucan synthesis pathway. For example, Liu et al . [22] described that a C. albicans culture treated with caspofungin exhibited modifi ed expression patterns of 19 cell wall maintenance genes compared to a control without treatment. This suggests that alternative resistance mechanisms to echinocandins may exist. In this study, the authors described a laboratory mutant called CaInR, which was capable of growing in the presence of up to 8 μ g ml Ϫ1 of caspofungin without FKS1 mutations. The analysis of the cell wall content of CaInR showed that it had a lower β 1,3 glucan content than the reference strain from which it was derived. This fi nding was noted both without (0.43 ϫ ) and with (0.35 ϫ ) induction with CAS. Since the FKS1 gene of CaInR showed no mutations and was not up-or down-regulated (personal datas), and since the β 1,3 glucan content of CaInR decreased when the antifungal drug was added in the culture medium, this suggested that the Fks1p enzymatic sub-unit was functioning normally and was still susceptible to CAS action in CaInR. However, the low initial level of β 1,3 glucan in CaInR (46.9 μ g mg Ϫ1 of cells versus 106.9 μ g mg Ϫ 1 in CaInS) seemed to indicate that the β 1,3 glucan synthesis pathway was somehow altered in that strain, although the mechanisms involved were unclear and should be investigated further.
The low β glucan content in the CaInR strain mimicked the situation observed in FKS1 defective yeast. As described for S. cerevisiae [23] , chitin biosynthesis can play a compensatory role to maintain the cell wall integrity and thus enable the yeast to survive. This mechanism can also be supposed for CaInR. Indeed, while the CaInS strain exhibited an average chitin content for a wild-type cell which increased in the presence of CAS as described elsewhere [6, 7] , the CaInR corresponding mutant showed, comparatively, a higher chitin content both in the absence and presence of CAS.
CaInR had a higher chitin content (2.3 ϫ ) when compared with CaInS in the absence of CAS, i.e., without any induction infl uence. This chitin concentration remained constant in the presence of CAS as no signifi cant increase in this cell wall component was observed after the addition of the antifungal drug into the culture medium. In other studies, chitin synthesis rescue was observed only under CAS infl uence by up-regulation of the chitin synthase genes (especially the CHS3 gene; [7] ). In the present study, CaInR showed no up-regulation of expression of its CHS3 gene or for that matter, the CHS1 or CHS8 genes. The only up-regulation observed in CaInR that was both statistically and biologically relevant, concerned the CHS2 gene but then only in the presence of CAS. Moreover, this up-regulation was observed both in CaInS and CaInR under CAS stimulation but not in the absence of the antifungal drug. These results showed that the echinocandin stimulation was not responsible for the higher chitin content of CaInR. Furthermore, CaInR showed no down-regulation of any of the chitinase genes.
Because neither up-nor down-regulation of any of the chitin biosynthesis pathway genes appeared to be responsible for the initial higher chitin content of CaInR, another hypothesis, such as potentially deleterious point mutations in chitinase genes, was investigated. Two chitinases genes exhibited no mutations ( CHT1 and CHT4 ), whereas two others showed several mutations (three mutations in CHT2 and two mutations in CHT3 ). These mutations led to P460S, Q462K and A479S substitutions in CHT2 and K97N and N233D substitutions in CHT3. These mutations may have a negative effect on the enzymatic activity of one or both proteins. Indeed, although these mutations occurred outside of the catalytic site, one predicted substitution in Cht2p may be particularly drastic because it changed a proline to a serine (P460S). The other substitutions in Cht2p appear to be less important but a possible effect on the enzymatic activity of this protein cannot be excluded. Although these mutations must be precisely examined to determine their effects, one or several of them may have resulted in an activity defect of the Cht2p enzyme, leading to the particular fi lamentation phenotype of CaInR (i.e., poor fi lamentation capability), which is in accordance with a previously described cht2 mutant strain [24] .
Concerning Cht3p, both substitutions were localized in the active enzymatic site and substrate binding cleft, suggesting a possible effect on the enzymatic activity of this protein in our laboratory mutant. Indeed, this strain had highly reduced chitinase activity in cell lysis supernatants (34% of the chitinase activity present in the wild-type CaInS strain). This is in accordance with a previously described cht3 Δ mutant [19] . CaInR also had a reduced chitinase activity in the culture supernatant (36% of the chitinase activity detected for the wild-type CaInS strain). Because Cht3p is a secreted protein [19, 20] , this is also in accordance with a defi cient Cht3p activity in our laboratory mutant strain. Although confi rmation by site-directed mutagenesis is needed to assess precisely if the mutations in CHT2 and/or CHT3 are responsible for the abnormal hyphae formation and the low chitinase phenotypes, all of these observations may explain the constitutive chitin increase observed in CaInR.
In this study, we described a laboratory mutant with a high MIC for caspofungin without mutations in its FKS1 gene. This mutant had a constitutive (i.e., without drug induction) low level of β 1-3 glucan associated with a constitutive high level of chitin. This high level of chitin was possibly the result of point mutations within the CHT2 and/ or the CHT3 gene and may enable that strain to survive with a low amount of ß glucan and thus to survive in the presence of caspofungin. The precise effect of each of these mutations will be explored in future studies.
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